Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).

Guldbrandsen A, Farag YM, Lereim RR, Berven FS, Barsnes H.

Methods Mol Biol. 2019;2044:377-391. doi: 10.1007/978-1-4939-9706-0_25.

PMID:
31432427
2.

Renal pathology practice globally: identifying needs and meeting the challenge.

Bijol V, Farag YMK, Harris DCH, Levin A, Roy-Chaudhury P, Singh AK, Jhaveri KD.

Kidney Int. 2019 Aug;96(2):258-261. doi: 10.1016/j.kint.2018.10.040. No abstract available.

PMID:
31331460
3.

Shared decision-making aid for juvenile idiopathic arthritis: moving from informative patient education to interactive critical thinking.

El Miedany Y, El Gaafary M, Lotfy H, El Aroussy N, Mekkawy D, Nasef SI, Farag Y, Almedany S, Wassif G; PRINTO Egypt.

Clin Rheumatol. 2019 Nov;38(11):3217-3225. doi: 10.1007/s10067-019-04687-y. Epub 2019 Jul 20.

PMID:
31327085
4.

Dose-response association between vitamin D deficiency and atopic dermatitis in children, and effect modification by gender: a case-control study.

Ahmed Mohamed A, Salah Ahmed EM, Farag YMK, Bedair NI, Nassar NA, Ghanem AIM.

J Dermatolog Treat. 2019 Aug 2:1-6. doi: 10.1080/09546634.2019.1643447. [Epub ahead of print]

PMID:
31296076
5.

Assessment of Epicardial Adipose Tissue Thickness in Children with Familial Mediterranean Fever.

Ghobrial EE, Farag YM, Abdul-Aziz DM, Omar MA.

J Trop Pediatr. 2019 Jun 30. pii: fmz040. doi: 10.1093/tropej/fmz040. [Epub ahead of print]

PMID:
31257436
6.

Facilitating patient-centered care: the development of illustrated multidimensional patient-reported outcome measures for children/adolescents with juvenile idiopathic arthritis.

El Miedany Y, El Gaafary M, Lotfy H, El Aroussy N, Mekkawy D, Nasef SI, Elderiny G, Farag Y, Hassan M.

Clin Rheumatol. 2019 Aug;38(8):2219-2226. doi: 10.1007/s10067-019-04490-9. Epub 2019 Mar 5.

PMID:
30834997
7.

Intima media thickness as an early predictor of atherosclerosis in Egyptian children with familial Mediterranean fever.

Mahmoud SSE, Ismail NA, Farag YM, Hashem RH, Ibrahim MH, Salah MM, Tous AN.

Arch Med Sci Atheroscler Dis. 2018 Aug 7;3:e106-e111. doi: 10.5114/amsad.2018.77545. eCollection 2018.

8.

Serum IL 4 and its gene polymorphism (rs79071878) in Egyptian children with familial Mediterranean fever.

Marzouk H, Farag Y, El-Hanafi HM, Ibrahim E.

Clin Rheumatol. 2018 Dec;37(12):3397-3403. doi: 10.1007/s10067-018-4214-z. Epub 2018 Jul 17.

PMID:
30014360
9.

Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial.

Elshal AM, Atwa AM, El-Nahas AR, El-Ghar MA, Gaber A, Elsawy E, Hashem A, Farag Y, Farg H, Elsorougy A, Fouda M, Nabeeh H, Mosbah A.

World J Urol. 2018 Nov;36(11):1845-1852. doi: 10.1007/s00345-018-2319-2. Epub 2018 May 7.

PMID:
29736609
10.

Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.

Badr AMM, Farag Y, Abdelshafy M, Riad NM.

Clin Rheumatol. 2018 Feb;37(2):451-458. doi: 10.1007/s10067-017-3812-5. Epub 2017 Sep 9.

PMID:
28887660
11.

Serum vitamin D level in Egyptian children with Familial Mediterranean fever.

Lotfy HM, Marzouk H, Farag Y, Salah A, Taher H, Nabih M, Rashed L, El-Garf K.

Immunol Lett. 2017 May;185:74-78. doi: 10.1016/j.imlet.2017.03.001. Epub 2017 Mar 21.

PMID:
28341008
12.

Ocular Manifestations in Children with Juvenile-Onset Systemic Lupus Erythematosus.

Gawdat G, El-Fayoumi D, Marzouk H, Farag Y.

Semin Ophthalmol. 2018;33(4):470-476. doi: 10.1080/08820538.2017.1301497. Epub 2017 Mar 24.

PMID:
28340314
13.

Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever.

Lofty HM, Marzouk H, Farag Y, Nabih M, Khalifa IA, Mostafa N, Salah A, Rashed L, El Garf K.

Int J Rheumatol. 2016;2016:7354018. doi: 10.1155/2016/7354018. Epub 2016 Dec 13.

14.

Serum vitamin D and sex hormones levels in men and women: The Multi-Ethnic Study of Atherosclerosis (MESA).

Zhao D, Ouyang P, de Boer IH, Lutsey PL, Farag YM, Guallar E, Siscovick DS, Post WS, Kalyani RR, Billups KL, Michos ED.

Maturitas. 2017 Feb;96:95-102. doi: 10.1016/j.maturitas.2016.11.017. Epub 2016 Nov 29.

15.

Thromboembolic events in patients with inflammatory bowel disease.

Algahtani FH, Farag YM, Aljebreen AM, Alazzam NA, Aleem AS, Jabri FF, Rajab MH, Shoukri MM.

Saudi J Gastroenterol. 2016 Nov;22(6):423-427. doi: 10.4103/1319-3767.195558.

16.

CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.

Guldbrandsen A, Farag Y, Kroksveen AC, Oveland E, Lereim RR, Opsahl JA, Myhr KM, Berven FS, Barsnes H.

Mol Cell Proteomics. 2017 Feb;16(2):300-309. doi: 10.1074/mcp.O116.064477. Epub 2016 Nov 27.

17.

Study of serum syndecan-1 levels in a group of Egyptian juvenile systemic lupus erythematosus patients.

Mosaad NA, Lotfy HM, Farag YM, Mahfouz RH, Shahin RM.

Immunol Lett. 2017 Jan;181:16-19. doi: 10.1016/j.imlet.2016.11.005. Epub 2016 Nov 9.

PMID:
27838471
18.

Vitamin D deficiency is independently associated with greater prevalence of erectile dysfunction: The National Health and Nutrition Examination Survey (NHANES) 2001-2004.

Farag YMK, Guallar E, Zhao D, Kalyani RR, Blaha MJ, Feldman DI, Martin SS, Lutsey PL, Billups KL, Michos ED.

Atherosclerosis. 2016 Sep;252:61-67. doi: 10.1016/j.atherosclerosis.2016.07.921. Epub 2016 Jul 29.

19.

Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows.

Aasebø E, Mjaavatten O, Vaudel M, Farag Y, Selheim F, Berven F, Bruserud Ø, Hernandez-Valladares M.

J Proteomics. 2016 Aug 11;145:214-225. doi: 10.1016/j.jprot.2016.03.049. Epub 2016 Apr 20.

PMID:
27107777
20.

The International Society of Nephrology (ISN) and the American Nephrologists of Indian Origin (ANIO) Online Clinical Nephropathology Certificate (CNC) program.

Bijol V, Farag YMK, Shah S, Feehally J, Singh AK.

Kidney Int. 2016 May;89(5):966-968. doi: 10.1016/j.kint.2015.11.035. No abstract available.

PMID:
27083269
21.

Prevalence of Hyperparathyroidism, Mineral and Bone Disorders in Children with Advanced Chronic Kidney Disease.

El Desoky S, Farag YM, Safdar E, Shalaby MA, Singh AK, Kari JA.

Indian J Pediatr. 2016 May;83(5):420-5. doi: 10.1007/s12098-015-1986-x. Epub 2016 Jan 30.

PMID:
26830276
22.

Mean Platelet Volume and Splenomegaly as Useful Markers of Subclinical Activity in Egyptian Children with Familial Mediterranean Fever: A Cross-Sectional Study.

Marzouk H, Lotfy HM, Farag Y, Rashed LA, El-Garf K.

Int J Chronic Dis. 2015;2015:152616. doi: 10.1155/2015/152616. Epub 2015 Jul 13.

23.

Distributed and interactive visual analysis of omics data.

Farag Y, Berven FS, Jonassen I, Petersen K, Barsnes H.

J Proteomics. 2015 Nov 3;129:78-82. doi: 10.1016/j.jprot.2015.05.029. Epub 2015 Jun 3.

PMID:
26047716
24.

Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus.

Garf KE, Marzouk H, Farag Y, Rasheed L, Garf AE.

Rheumatol Int. 2015 Sep;35(9):1535-40. doi: 10.1007/s00296-015-3245-x. Epub 2015 Mar 15.

PMID:
25773657
25.

Predictors of renal replacement therapy and mortality in children with chronic kidney disease.

Kari JA, El Desoky SM, Farag YM, Singh AK.

Saudi Med J. 2015 Jan;36(1):32-9. doi: 10.15537/smj.2015.1.9774.

26.

Outcome of acute kidney injury in pediatric patients admitted to the intensive care unit.

Shalaby M, Khathlan N, Safder O, Fadel F, Farag YM, Singh AK, Kari JA.

Clin Nephrol. 2014 Dec;82(6):379-86.

PMID:
25412199
27.

Detection of Mediterranean fever gene mutations in Egyptian children with inflammatory bowel disease.

Salah S, El-Shabrawi M, Lotfy HM, Shiba HF, Abou-Zekri M, Farag Y.

Int J Rheum Dis. 2016 Aug;19(8):806-13. doi: 10.1111/1756-185X.12482. Epub 2014 Oct 8.

PMID:
25292286
28.

MEFV gene mutations in Egyptian children with Henoch-Schonlein purpura.

Salah S, Rizk S, Lotfy HM, El Houchi S, Marzouk H, Farag Y.

Pediatr Rheumatol Online J. 2014 Sep 9;12:41. doi: 10.1186/1546-0096-12-41. eCollection 2014.

29.

In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR).

Guldbrandsen A, Vethe H, Farag Y, Oveland E, Garberg H, Berle M, Myhr KM, Opsahl JA, Barsnes H, Berven FS.

Mol Cell Proteomics. 2014 Nov;13(11):3152-63. doi: 10.1074/mcp.M114.038554. Epub 2014 Jul 18.

30.

Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study.

Farag YM, Mittal BV, Keithi-Reddy SR, Acharya VN, Almeida AF, C A, Ballal HS, Gaccione P, Issacs R, Jasuja S, Kirpalani AL, Kher V, Modi GK, Nainan G, Prakash J, Rajapurkar MM, Rana DS, Sreedhara R, Sinha DK, Shah BV, Sunder S, Sharma RK, Seetharam S, Raju TR, Singh AK.

BMC Nephrol. 2014 Mar 6;15:42. doi: 10.1186/1471-2369-15-42.

31.

Prevalence of vitamin D deficiency in Saudi adults.

Alsuwadia AO, Farag YM, Al Sayyari AA, Mousa DH, Alhejaili FF, Al-Harbi AS, Housawi AA, Mittal BV, Singh AK.

Saudi Med J. 2013 Aug;34(8):814-8.

PMID:
23974452
32.

Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study.

Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, Almeida AF, Channakeshavamurthy A, Ballal HS, P G, Issacs R, Jasuja S, Kirpalani AL, Kher V, Modi GK, Nainan G, Prakash J, Rana DS, Sreedhara R, Sinha DK, V SB, Sunder S, Sharma RK, Seetharam S, Raju TR, Rajapurkar MM.

BMC Nephrol. 2013 May 28;14:114. doi: 10.1186/1471-2369-14-114.

33.

Renal impairment in children with posterior urethral valves.

Kari JA, El-Desoky S, Farag YM, Mosli H, Altyieb AM, Al Sayad A, Radawi O, Ghabra H, Basnawi F, Bahrawi O, Singh A, Farsi H.

Pediatr Nephrol. 2013 Jun;28(6):927-31. doi: 10.1007/s00467-012-2390-7. Epub 2012 Dec 24.

PMID:
23263712
34.

Chronic kidney disease in the Arab world: a call for action.

Farag YM, Kari JA, Singh AK.

Nephron Clin Pract. 2012;121(3-4):c120-3. doi: 10.1159/000345149. Epub 2012 Nov 28. Review.

35.

Modulation of platelet activation in chronic kidney disease patients on erythropoiesis-stimulating agents.

Farag YM, Keithy-Reddy SR, Mittal BV, Bansal V, Fareed J, Singh AK.

Clin Appl Thromb Hemost. 2012 Sep;18(5):453-61. doi: 10.1177/1076029611431954. Epub 2012 Apr 11.

PMID:
22496088
36.

Diabetic nephropathy in the Arab Gulf countries.

Farag YM, Al Wakeel JS.

Nephron Clin Pract. 2011;119(4):c317-22; discussion c322-3. doi: 10.1159/000328909. Epub 2011 Nov 3. Review.

37.

Anemia, inflammation and health-related quality of life in chronic kidney disease patients.

Farag YM, Keithi-Reddy SR, Mittal BV, Surana SP, Addabbo F, Goligorsky MS, Singh AK.

Clin Nephrol. 2011 Jun;75(6):524-33.

PMID:
21612756
38.

Metabolic syndrome and the non-neoplastic kidney.

Farag YM.

Adv Anat Pathol. 2011 Mar;18(2):173; author reply 174. doi: 10.1097/PAP.0b013e3182026d60. No abstract available.

PMID:
21326015
39.

Development of shellac-coated sustained release pellet formulations.

Farag Y, Leopold CS.

Eur J Pharm Sci. 2011 Mar 18;42(4):400-5. doi: 10.1016/j.ejps.2011.01.006. Epub 2011 Jan 18.

PMID:
21251975
40.

Investigation of drug release from pellets coated with different shellac types.

Farag Y, Leopold CS.

Drug Dev Ind Pharm. 2011 Feb;37(2):193-200. doi: 10.3109/03639045.2010.504210. Epub 2010 Aug 12.

PMID:
21073321
41.

Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study.

Alsuwaida AO, Farag YM, Al Sayyari AA, Mousa D, Alhejaili F, Al-Harbi A, Housawi A, Mittal BV, Singh AK.

Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1066-72.

42.

Diabesity: an overview of a rising epidemic.

Farag YM, Gaballa MR.

Nephrol Dial Transplant. 2011 Jan;26(1):28-35. doi: 10.1093/ndt/gfq576. Epub 2010 Nov 2. Review.

PMID:
21045078
43.

Influence of the inlet air temperature in a fluid bed coating process on drug release from shellac-coated pellets.

Farag Y, Leopold CS.

Drug Dev Ind Pharm. 2011 Mar;37(3):320-8. doi: 10.3109/03639045.2010.512292. Epub 2010 Sep 6.

PMID:
20815796
44.

Kidney pathological changes in metabolic syndrome: a cross-sectional study.

Alexander MP, Patel TV, Farag YM, Florez A, Rennke HG, Singh AK.

Am J Kidney Dis. 2009 May;53(5):751-9. doi: 10.1053/j.ajkd.2009.01.255. Epub 2009 Apr 1.

45.

De novo multifocal renal cell carcinoma in the renal allograft.

Alexander MP, Farag YM, Mittal BV, Rennke HG, Tullius SG, Singh AK.

Kidney Int. 2009 Jan;75(1):111-4. doi: 10.1038/ki.2008.228. Epub 2008 Jun 18. No abstract available.

46.

The Case: an unknown toxin.

Farag YM, Bayliss GP, Singh AK.

Kidney Int. 2008 May;73(10):1201-2. doi: 10.1038/ki.2008.38. No abstract available.

47.

Lithium toxicity: a double-edged sword.

Alexander MP, Farag YM, Mittal BV, Rennke HG, Singh AK.

Kidney Int. 2008 Jan;73(2):233-7. Epub 2007 Oct 17. No abstract available.

48.

Rapidly accumulating spontaneous pulmonary hematoma.

Sameh IS, Elshabrawii M, Elsaeid AS, Farag YA, Abulela S, El Salid MM.

J Thorac Cardiovasc Surg. 2005 Jan;129(1):233-4; author reply 234-5. No abstract available.

49.

Rate of release of organic carboxylic acids from ion-exchange resins.

Farag Y, Nairn JG.

J Pharm Sci. 1988 Oct;77(10):872-5.

PMID:
3236231
50.

Insulin tolerance test and tolbutamide tolerance test in acromegaly.

Farag Y, Gaafar MA.

J Egypt Med Assoc. 1977;60(9-12):839-50. No abstract available.

PMID:
753863

Supplemental Content

Support Center